Business Description
Ribomic Inc
ISIN : JP3974850004
Total Employee Number:
25Description
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.96 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 13.03 | |||||
Beneish M-Score | -1.18 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -69.5 | |||||
3-Year EBITDA Growth Rate | 25 | |||||
3-Year EPS without NRI Growth Rate | 24.2 | |||||
3-Year FCF Growth Rate | 26 | |||||
3-Year Book Growth Rate | -24.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.32 | |||||
9-Day RSI | 35.25 | |||||
14-Day RSI | 33.86 | |||||
3-1 Month Momentum % | -24.21 | |||||
6-1 Month Momentum % | -4 | |||||
12-1 Month Momentum % | -29.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 21.68 | |||||
Quick Ratio | 21.66 | |||||
Cash Ratio | 20.93 | |||||
Days Sales Outstanding | 67.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15 | |||||
Shareholder Yield % | -27.92 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -40237.73 | |||||
Net Margin % | -38178.67 | |||||
EBITDA Margin % | -40104.57 | |||||
FCF Margin % | -37367.67 | |||||
OCF Margin % | -37028.77 | |||||
ROE % | -37.67 | |||||
ROA % | -36.06 | |||||
ROIC % | -1367.79 | |||||
3-Year ROIIC % | -4342.9 | |||||
ROC (Joel Greenblatt) % | -12339.92 | |||||
ROCE % | -39.7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1072.73 | |||||
PB Ratio | 1.13 | |||||
Price-to-Tangible-Book | 1.13 | |||||
EV-to-EBIT | -0.39 | |||||
EV-to-EBITDA | -0.39 | |||||
EV-to-Revenue | 157.93 | |||||
EV-to-FCF | -0.42 | |||||
| Price-to-Net-Current-Asset-Value | 1.15 | |||||
| Price-to-Net-Cash | 1.19 | |||||
Earnings Yield (Greenblatt) % | -256.41 | |||||
FCF Yield % | -33.96 |
GF Valueâ„¢
Ribomic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ribomic Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ribomic Inc
No articles.